疫苗市场概况分析

doi:10.13523/j.cb.20170116

中国生物工程杂志

2017, Vol. 37

Issue (1): 111-118 DOI: 10.13523/j.cb.20170116

行业分析

疫苗市场概况分析

李敏

江西省科学院科技战略研究所南昌 330096

The Analysis of Vaccine Market

LI Min

Institute of Science and Technology Strategy, Jiangxi Academy of Sciences, Nanchang 330096, China

全文: PDF(667 KB) HTML

摘要：

疫苗是目前人类预防疾病最有效的武器，是每个人都脱离不开的公共医疗产品，为全人类的健康做出了巨大贡献。目前全球大约有68种疫苗上市销售，能够预防34种疾病。近年来全球疫苗市场稳步增长，疫苗销售额逐年增加，2015年全球疫苗销售总额达到296亿美元，辉瑞、默沙东、赛诺菲、葛兰素史克、诺华五大巨头占据市场销售额的85%以上，多种疫苗产品取得较好销售成绩。中国疫苗市场规模也在迅速增长，2015年疫苗市场产值达到183.7亿元，2015年疫苗批签发数量达到7.04亿瓶，疫苗生产企业产品种类不断丰富，疫苗研发能力逐渐增强。新兴国家疫苗市场正在逐步发展，其中印度表现优异，中国疫苗产业国际化方面虽落后于印度，但也取得了不少进步，走向国际市场已经成为不可逆转的趋势。

关键词： 疫苗; 新兴国家; 疫苗市场

Abstract:

Vaccine is the most effective weapon for the prevention of the disease, which is the public medical product that everyone can't be separated from and has made great contributions to the health of all mankind. There are about 68 kinds of vaccines in the global market at present and can prevent 34 kinds of diseases. Global vaccine markets maintain steady growth. Vaccine sales increased year by year and the market sales were 29.6 billion dollars in 2015. The top 5 companies, Pfizer, Merck, Sanofi, GSK, Novartis, occupied more than 85% of the market share. A variety of vaccine products had good sales performance. China vaccine markets also grow consistently with a market value of 18.37 billion in 2015. The issued amount of vaccine was 704 million bottles in 2015. The types of vaccine productions are increased and the ability of vaccine research and development is gradually strengthened. The vaccine markets in emerging countries are gradually developing and India performs excellently. The internationalization of Chinese vaccine industry is not as good as India, but it also made a lot of progress. Chinese vaccine industry entering the international market has become an irreversible trend in the future.

Key words: Vaccine Emerging countries Vaccine market

收稿日期: 2016-07-07 出版日期: 2017-01-25

ZTFLH:

Q819

基金资助:

江西省科学院资助项目（2014-XTPH1-28，2014-YYB-28）

通讯作者: 李敏 E-mail: limin20140701@163.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

引用本文:

李敏. 疫苗市场概况分析[J]. 中国生物工程杂志, 2017, 37(1): 111-118.

LI Min. The Analysis of Vaccine Market. China Biotechnology, 2017, 37(1): 111-118.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20170116 或 https://manu60.magtech.com.cn/biotech/CN/Y2017/V37/I1/111

[1] 高云华, 吴曙霞, 刁天喜. 预防疫苗产业市场的现状与发展趋势. 中国新药杂志, 2008, 17(20):1736-1738. Gao Y H, Wu SH X, Diao T X. The current status and trends of the preventive vaccine market. Chinese Journal of New Drugs, 2008, 17(20):1736-1738.
[2] 王福清, 易静薇, 赵晓嬿, 等. 我国疫苗产业发展现状与展望. 中国生化药物杂志, 2009, 30(4):287-290. Wang F Q, Yi J W, Zhao X Y, et al. The development status and perspective of vaccine industry in China. Chinese Journal of Biochemical Pharmaceutics, 2009, 30(4):287-290.
[3] 丁辉. 生物制药前景广阔, 细分行业各有千秋. 江苏科技信息, 2011, (5):40-42. Ding H. Good prospects for biopharmaceutical industry with merits in each segments. Jiangsu Science and Technology Information, 2011, (5):40-42.
[4] 王永庆. 加快疫苗产业自主发展,确保国家生物安全. 经济界, 2015, (3):6-7. Wang Y Q. Accelerating the development of the vaccine industry, ensuring the safety of national biological. Economic Affairs, 2015, (3):6-7.
[5] Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature, 2011, 473(7348):463-469.
[6] 于盟. 全球疫苗市场综述. 精细与专用化学品, 2015, 23(11):10-12. Yu M. Overview on the global vaccine market. Fine and Specialty Chemicals, 2015, 23(11):10-12.
[7] Kennedy R B, Ovsyannikova I G, Lambert N D, et al. The personal touch:strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines, 2014, 13(5):657-669.
[8] Delany I, Rappuoli R, Seib K L. Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med, 2013, 3(5):a012476.
[9] 于盟.中印疫苗产业国际化对比. 医药经济报, 2015-05-27(003版). Yu M. International comparison of vaccine industry in China and India. Medicine Economic Report, 2015-95-27(003).
[10] 阿丽塔, 刘晓婷, 孙灵芝. 全球疫苗产业现状与发展趋势. 2011, 20(22):16-18. A L T, Liu X T, Sun L Z. Current status and development trend of global vaccine industry. China Pharmaceuticals, 2011, 20(22):16-18.

[1]	肖云喜,张俊河,杨雯雯,程洪伟. 用于疫苗生产的人二倍体细胞研究进展^*[J]. 中国生物工程杂志, 2021, 41(11): 74-81.
[2]	朱潇静,王芮,张欣欣,靳家鑫,路闻龙,丁大顺,霍翠梅,李青梅,孙爱军,庄国庆. 利用细菌人工染色体技术构建整合F基因的重组MDV疫苗株^*[J]. 中国生物工程杂志, 2021, 41(10): 33-41.
[3]	程旭,杨雨睛,吴赛男,侯勤龙,李咏梅,韩慧明. 金黄色葡萄球菌SarA、IcaA及其融合基因的DNA疫苗构建及在小鼠免疫应答中的初步研究 ^*[J]. 中国生物工程杂志, 2020, 40(7): 41-50.
[4]	刘珍珍,田大勇. 狂犬病疫苗蔗糖密度梯度离心纯化工艺开发 ^*[J]. 中国生物工程杂志, 2020, 40(4): 25-33.
[5]	钱颖,钱晨,白晓庆,王晶晶. 免疫佐剂在肿瘤免疫疗法中的应用进展 ^*[J]. 中国生物工程杂志, 2020, 40(3): 96-103.
[6]	谢华玲,吕璐成,杨艳萍. 全球冠状病毒疫苗专利分析[J]. 中国生物工程杂志, 2020, 40(1-2): 57-64.
[7]	井汇源,段二珍,董望. 体外转录的自我复制型mRNA疫苗研究进展^*[J]. 中国生物工程杂志, 2020, 40(12): 25-30.
[8]	廖小艳,陈丽丽. COVID-19疫苗研究现状^*[J]. 中国生物工程杂志, 2020, 40(12): 8-17.
[9]	冯雪娇,侯海龙,喻琼,王俊姝. 我国宫颈癌疫苗市场分析及对策研究^*[J]. 中国生物工程杂志, 2020, 40(11): 96-101.
[10]	高彦,杜晶晶,王斌,刘琦,申志强. 气相色谱法对狂犬病疫苗灭活工艺中β-丙内酯研究[J]. 中国生物工程杂志, 2019, 39(6): 25-31.
[11]	杨琳,傅哲彦,吕正兵,舒建洪. 免疫佐剂分类及作用机制[J]. 中国生物工程杂志, 2019, 39(5): 114-119.
[12]	许嘉越,李紫倩,张革. 登革病毒3'UTRΔ30系列疫苗的研究进展[J]. 中国生物工程杂志, 2019, 39(3): 97-104.
[13]	蒋析文,董子维,刘悦,朱小亚. 生物标记物与精准医疗研究进展[J]. 中国生物工程杂志, 2019, 39(2): 74-81.
[14]	孙思,邱喻兰,颜菊荣,杨静,吴光英,王玲,胥文春. 重组质粒pcDNA3-dnaJ/蛋白DnaJ异源免疫诱导Th1和Th17细胞免疫应答抵抗肺炎链球菌感染 ^*[J]. 中国生物工程杂志, 2019, 39(12): 9-17.
[15]	郭乐,王淑娥,何萌,张帆,刘宏鹏,刘昆梅. 幽门螺杆菌多价表位疫苗CWAE的表达及其免疫学性质的研究 ^*[J]. 中国生物工程杂志, 2019, 39(12): 1-8.

Viewed

Full text

Abstract

Cited

Shared

Discussed